Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 14505
Country/Region: Nigeria
Year: 2017
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $8,755,493 Additional Pipeline Funding: $20,720,888

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $347,135
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $236,170
Care: Pediatric Care and Support (PDCS) $1,759,569
Laboratory Infrastructure (HLAB) $712,164
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Testing: HIV Testing and Counseling (HVCT) $2,456,992
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $2,593,101
Treatment: Pediatric Treatment (PDTX) $650,362
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2018 3,411
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 1,613
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2018 3,745
GEND_GBV_DSD Number of people receiving post-GBV care 2018 5,358
HTC_TST_DSD By Test Result: Positive 2018 84,549
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 2,663,527
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2018 60,701
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2018 1,396
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 1,430
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 501
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 1,151
HTC_TST_DSD Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 360
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Other: <15, Female, Negative 2018 6,504
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Other: <15, Female, Positive 2018 65
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Other: <15, Male, Negative 2018 5,322
HTC_TST_DSD Service Delivery Point by Agg Age (Community) Other: 15+, Male, Positive 2018 55
HTC_TST_DSD Service Delivery Point by Agg Age (Community) VCT Mod: 15+, Female, Negative 2018 410
HTC_TST_DSD Service Delivery Point by Agg Age (Community) VCT Mod: 15+, Female, Positive 2018 27
HTC_TST_DSD Service Delivery Point by Agg Age (Community) VCT Mod: 15+, Male, Negative 2018 336
HTC_TST_DSD Service Delivery Point by Agg Age (Community) VCT Mod: 15+, Male, Positive 2018 22
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: Unknown Age, Negative 2018 684,887
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) ANC: Unknown Age, Positive 2018 12,336
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 289
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 18
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 223
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 6
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 14,050
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 820
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 11,492
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 645
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 68,191
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 1,007
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 55,788
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 755
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 573,610
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 28,682
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 469,311
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 23,445
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 1,184
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 98
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 943
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 58
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 22,632
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 2,232
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 18,496
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 1,795
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) TB: Unknown Age, Female, Negative 2018 1
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 67,826
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 3,583
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 55,494
HTC_TST_DSD Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 2,939
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Negative 2018 36,269
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Female, Positive 2018 136
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Negative 2018 29,673
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: <15, Male, Positive 2018 110
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 148,863
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 1,893
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 121,799
HTC_TST_DSD Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 1,548
HTC_TST_DSD Sum of Test Result disaggregates 2018 84,549
OVC_SERV_DSD Age/Sex: <1 2018 992
OVC_SERV_DSD Age/Sex: 1-9 2018 31,618
OVC_SERV_DSD Age/Sex: 10-14 Female 2018 9,901
OVC_SERV_DSD Age/Sex: 10-14 Male 2018 10,238
OVC_SERV_DSD Age/Sex: 15-17 Female 2018 4,698
OVC_SERV_DSD Age/Sex: 15-17 Male 2018 4,881
OVC_SERV_DSD By: Age/sex: 18-24 Female 2018 1,255
OVC_SERV_DSD By: Age/sex: 25+ Female 2018 6,330
OVC_SERV_DSD By: Age/sex: Male 18-24 2018 915
OVC_SERV_DSD By: Age/sex: Male 25+ 2018 1,112
OVC_SERV_DSD Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 71,940
OVC_SERV_DSD Program Completion: Active 2018 36,656
OVC_SERV_DSD Program Completion: Graduation 2018 35,284
OVC_SERV_DSD Sum of Age/Sex disaggregates 2018 29,718
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 7,079
PMTCT_ART_DSD New on ART 2018 13,773
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 20,852
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 708,048
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 20,895
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 3,838
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 15,445
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 297
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 1,315
PMTCT_STAT_DSD By Age (Denominator): Unknown Age 2018 745,315
PMTCT_STAT_DSD By Age (Numerator): Unknown Age 2018 708,048
PMTCT_STAT_DSD By Number of known positives: Unknown Age 2018 10,825
PMTCT_STAT_DSD By Number of new negative: Unknown Age 2018 684,887
PMTCT_STAT_DSD By Number of new positives: Unknown Age 2018 12,336
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 708,048
TB_ART_DSD Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 149
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 136
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,371
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,243
TB_ART_DSD Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 332
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 353
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 1,947
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 1,819
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 3,799
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 3,551
TB_PREV_DSD By Age/Sex (Denominator): <15, Female 2018 5,762
TB_PREV_DSD By Age/Sex (Denominator): <15, Male 2018 5,409
TB_PREV_DSD By Age/Sex (Denominator): 15+, Female 2018 136,800
TB_PREV_DSD By Age/Sex (Denominator): 15+, Male 2018 59,962
TB_PREV_DSD By Age/Sex (Numerator): <15, Female 2018 4,041
TB_PREV_DSD By Age/Sex (Numerator): <15, Male 2018 3,797
TB_PREV_DSD By Age/Sex (Numerator): 15+, Female 2018 95,761
TB_PREV_DSD By Age/Sex (Numerator): 15+, Male 2018 41,961
TB_PREV_DSD By Therapy type (Denominator): 6-12 Month IPT 2018 207,933
TB_PREV_DSD By Therapy type (Numerator): 6-12 Month IPT 2018 145,560
TB_PREV_DSD The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 145,560
TB_PREV_DSD The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 207,933
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 419
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 382
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 4,474
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 4,027
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 708
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 644
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 6,330
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 5,686
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 10,739
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2018 11,931
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2018 7,430
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2018 6,753
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2018 182,907
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2018 80,338
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 277,428
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2018 14,183
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2018 263,245
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2018 277,428
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2018 2,171
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2018 1,758
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2018 50,503
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2018 21,099
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 75,531
TX_NEW_DSD Pregnancy status 2018 179
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2018 75,531
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 6,566
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 707
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 6,235
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 657
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 155,927
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 17,319
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 68,544
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 7,593
TX_PVLS_DSD Denominator: Indication: Routine 2018 237,272
TX_PVLS_DSD Denominator: Indication: Targeted 2018 26,276
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Routine 2018 7,529
TX_PVLS_DSD Denominator: Preg/BF by Indication: Pregnant Targeted 2018 837
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 263,528
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 237,193
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 5,911
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 638
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 5,619
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 592
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 140,315
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 15,581
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 61,707
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 6,830
TX_PVLS_DSD Numerator: Indication: Routine 2018 213,552
TX_PVLS_DSD Numerator: Indication: Targeted 2018 23,641
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Routine 2018 6,776
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Targeted 2018 752
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,501
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,540
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,089
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,215
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 172,676
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 155,665
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 75,982
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 68,503
TX_RET_DSD Denominator by Status: Pregnant 2018 8,367
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 236,923
TX_RET_DSD Numerator by Status: Pregnant 2018 7,533
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 263,248
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Female 2018 1,814
TX_TB_DSD Denominator: By Aggregated Age/Sex: <15, Male 2018 1,714
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Female 2018 43,648
TX_TB_DSD Denominator: By Aggregated Age/Sex:15+, Male 2018 19,148
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 16,178
TX_TB_DSD Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,786
TX_TB_DSD Denominator: By Screen Result: Negative 2018 46,410
TX_TB_DSD Denominator: By Screen Result: Positive 2018 19,914
TX_TB_DSD Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 17,964
TX_TB_DSD Number of ART patients who were screened for TB at least once during the reporting period 2018 66,324
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 13,273
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Female 2018 365
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Male 2018 319
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 8,747
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 3,822
Cross Cutting Budget Categories and Known Amounts Total: $5,267,061
Gender: Gender Equality $158,603
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Promoting gender-related policies and laws that increase legal protection
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Gender: Gender Based Violence (GBV) $1,699,958
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Operation Research
Education $24,040
Renovation $554,700
Food and Nutrition: Commodities $152,217
Economic Strengthening $118,728
Motor Vehicles: Purchased $526,079
Human Resources for Health $2,032,736